Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 641 participants.
Also called NCT01415531
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 641 participants
- Sponsor
- Registry
-
NCT01415531
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01415531. Randomized; triple masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2012-03 (actual). Results posted on 2013-05-16.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)
- Condition
- Hypertension
- Intervention (Drug)
- Nebivolol
- Intervention (Drug)
- Placebo
- Lead sponsor
- Forest Laboratories
Record details
- Record id
cardio:ct-nct01415531- Content hash
858cca55352f927447883f410acfea35ebc9dda5a9182344cf1f7d11e734d0ed